Publications
研究論文
- A derivative compound, HT-7, inhibits viral release by inducing cell surface BST2/Tetherin/CD317/HM1.24
- Potential role of APOBEC3 family proteins in SARS-CoV-2 replication
- Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
- Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236
- Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses
- Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
- SARS-CoV-2 inactivation: Assessing the efficacy of GO-anchored filters versus various commercial masks
- Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
- Virological characteristics of the SARS-CoV-2 BA.2.86 variant
- Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein
- Transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA.2.86 variant
- Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics
- APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1
- Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
- Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
- SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
- The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
- A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result
- Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike protein-mediated membrane fusion assay
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- Basic structure and cytocompatibility of giant membrane vesicles derived from paraformaldehyde-exposed human cells
- Lethal interactions of SARS-CoV-2 with graphene oxide: Implications for COVID-19 treatment
- A patient infected with SARS-CoV-2 over 100 days
- Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19. Cell Rep. 36, 109385, 2021.
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 29, 1124-1136.e11, 2021.